Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia

Author： Boyle P. Robertson C. Lowe F. Roehrborn C.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.55, Iss.4, 2000-04, pp. : 533-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia

By Boyle P. Robertson C. Manski R. Padley R.J. Roehrborn C.G.

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 717-722

Elsevier

Access to resources Recommend Favorite

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials

By Boyle P. Gould A.L. Roehrborn C.G.

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 398-405

Elsevier

Access to resources Recommend Favorite

Comparison of a phytotherapeutic agent (permixon) with an alphablocker. (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomised international study

By Debruyne F.

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 108-108

Elsevier

Access to resources Recommend Favorite

Comparison of a Phytotherapeutic Agent (Permixon) with an -Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

By Debruyne F. Koch G. Boyle P. Da Silva F.C. Gillenwater J.G. Hamdy F.C. Perrin P. Teillac P. Vela-Navarrete R. Raynaud J.-P. For the members of the PERMAL Study Group

European Urology, Vol. 41, Iss. 5, 2002-05 ,pp. : 497-507

Elsevier

Access to resources Recommend Favorite

Treatment of men with minimally symptomatic benign prostatic hyperplasia-PRO: the argument in favor

By Marks L.S.

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 781-783

Elsevier

Access to resources Recommend Favorite